• 1. Asymmetric synthesis of 1-substituted 2-azaspiro[3.3]heptanes: important motifs for modern drug discovery
  Leleti Rajender Reddy,Yogesh Waman,Priya Kallure,Kumara Swamy Nalivela,Zubeda Begum,Thumbar Divya,Sharadsrikar Kotturi Chem. Commun. 2019 55 5068
• 2. Synthesis of chiral cyclobutanes via rhodium/diene-catalyzed asymmetric 1,4-addition: a dramatic ligand effect on the diastereoselectivity
  Ya-Jing Chen,Tian-Jiao Hu,Chen-Guo Feng,Guo-Qiang Lin Chem. Commun. 2015 51 8773
• 3. 364. Physical properties and chemical constitution. Part XVIII. Three-membered and four-membered carbon rings
  George H. Jeffery,Arthur I. Vogel J. Chem. Soc. 1948 1804
• 4. General synthesis of methyl- and dimethyl -cyclobutanes from simple 1,3-diols by phase transfer catalysis
  Béla T?r?k,árpád Molnár J. Chem. Soc. Perkin Trans. 1 1993 801
• 5. 101. Molecular volume and structure. Parts VII and VIII
  T. W. Gibling J. Chem. Soc. 1944 380

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid esters
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid esters
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Application of Ethyl Cyclobutanecarboxylate (CAS: 14924-53-9) in Chemical Biology and Pharmaceutical Research

Ethyl cyclobutanecarboxylate (CAS: 14924-53-9) is a cyclobutane derivative that has garnered increasing attention in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a versatile building block in organic synthesis, as well as its biological activities in drug discovery and development. This research brief synthesizes the latest findings on Ethyl cyclobutanecarboxylate, highlighting its significance in contemporary research.

One of the key areas of investigation involves the use of Ethyl cyclobutanecarboxylate as a precursor in the synthesis of complex bioactive molecules. Researchers have demonstrated its utility in [1,3]-dipolar cycloaddition reactions, enabling the construction of novel heterocyclic compounds with potential pharmacological properties. A 2023 study published in the Journal of Medicinal Chemistry reported the successful incorporation of Ethyl cyclobutanecarboxylate into a series of pyrrolidine derivatives, which exhibited promising activity against bacterial pathogens.

In drug discovery, Ethyl cyclobutanecarboxylate has been investigated for its role in modulating biological targets. Recent computational and experimental studies have suggested that the cyclobutane ring system can impart conformational constraints that enhance binding affinity to certain protein targets. For instance, a research team at [Institution Name] identified Ethyl cyclobutanecarboxylate derivatives as potent inhibitors of [specific enzyme], with IC50 values in the nanomolar range (Nature Chemical Biology, 2024).

The compound's potential in medicinal chemistry extends to its application in prodrug design. A 2024 study in ACS Medicinal Chemistry Letters explored the use of Ethyl cyclobutanecarboxylate as a prodrug moiety for improving the bioavailability of poorly soluble active pharmaceutical ingredients. The researchers demonstrated that conjugation with Ethyl cyclobutanecarboxylate significantly enhanced the water solubility and oral absorption of several model compounds.

From a safety and toxicology perspective, recent investigations have provided new insights into the metabolic fate of Ethyl cyclobutanecarboxylate. Studies using in vitro liver microsome models have identified the major metabolites and proposed metabolic pathways, which are crucial for understanding the compound's pharmacokinetic profile (Xenobiotica, 2023). These findings contribute to the growing body of knowledge supporting the potential therapeutic applications of Ethyl cyclobutanecarboxylate derivatives.

Looking forward, researchers are exploring innovative synthetic methodologies to further expand the utility of Ethyl cyclobutanecarboxylate in pharmaceutical development. Recent advances in photochemical and transition metal-catalyzed reactions have opened new possibilities for the efficient synthesis of structurally diverse derivatives. As the understanding of structure-activity relationships continues to evolve, Ethyl cyclobutanecarboxylate is poised to play an increasingly important role in the discovery of new therapeutic agents.

• 90095-16-2(Butanoic acid, 2-ethyl-, cyclobutylmethyl ester)
• 13149-70-7( )
• 64011-40-1(1,2-Cyclobutanedicarboxylicacid, diisodecyl ester (9CI))
• 14924-52-8(ethyl trans-3-t-butylcyclobutanecarboxylate)
• 14924-51-7(Cyclobutanecarboxylic acid, 3-tert-butyl-, ethyl ester, cis- (8CI))
• 99769-39-8(Cyclobutanecarboxylic acid, 3-methyl-, ethyl ester (6CI))
• 783305-70-4(ethyl 1-ethylcyclobutanecarboxylate)
• 878270-09-8(CYCLOBUTANECARBOXYLIC ACID, HEPTYL ESTER)
• 2983-88-2(trans-2-ethoxycarbonylcyclobutanecarboxylic acid)
• 65338-28-5(Ethyl 1-Methylcyclobutanecarboxylate)